Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

INTRODUCTION: In the last decades, the therapeutic decision-making approach to metastatic renal cell cancer (mRCC) has dramatically changed thanks to the introduction in the treatment scenario of, first, anti-angiogenic agents and, afterward, immune-checkpoint inhibitors (ICIs). Immunotherapy is now...

Descripción completa

Detalles Bibliográficos
Autores principales: Raimondi, Alessandra, Sepe, Pierangela, Zattarin, Emma, Mennitto, Alessia, Stellato, Marco, Claps, Melanie, Guadalupi, Valentina, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434861/
https://www.ncbi.nlm.nih.gov/pubmed/32903369
http://dx.doi.org/10.3389/fonc.2020.01644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434861/
https://www.ncbi.nlm.nih.gov/pubmed/32903369
http://dx.doi.org/10.3389/fonc.2020.01644

Ejemplares similares